1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Topical Sinus Therapeutics Inc. has 1 pending office action assigned to 1 examiner. HALL, DEANNA K is the busiest examiner, with 1 pending matter.
The profile does not identify a technology area or art unit. Prosecution planning therefore centers on the individual examiner and the single outstanding action, rather than on broader portfolio specialization.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HALL, DEANNA K | 1 | 75.7% | +15.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18400993 | THERAPEUTIC USES AND METHODS OF DELIVERY OF VISCOUS COMPOSITIONS DURING PRE AND POST SURGICAL PERIODS, FOR TREATMENT OF RESPONSIVE DISEASES OF THE EAR, NOSE AND THROAT | HALL, DEANNA K | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18400993 | THERAPEUTIC USES AND METHODS OF DELIVERY OF VISCOUS COMPOSITIONS DURING PRE AND POST SURGICAL PERIODS, FOR TREATMENT OF RESPONSIVE DISEASES OF THE EAR, NOSE AND THROAT | HALL, DEANNA K | — | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTopical Sinus Therapeutics Inc. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Deanna K Hall has the most, with 1 of Topical Sinus Therapeutics Inc.'s pending office actions.
